Blog
3 Explosive Growth Stocks to Buy and Hold for the Next 10 Years
It's easy to get lured by the stock market's day-to-day movements and cash out when your stock pops, but real money is made only when you can hold on to your stocks for years. That's when you let
Is Compass Pathways Stock a Buy?
Despite having an IPO just three months ago, Compass Pathways (NASDAQ: CMPS) is already up a staggering 224% from its IPO price of $17. If you invested $10,000 in its first-ever public offering,
Watch Out! These 2 Stocks Might Cut Their Dividends
One of the biggest risks when investing in dividend stocks is that payouts are never a guarantee and a company can decide to cut or suspend its payments, often without warning. Not only is it a sign
The Average Mortgage Now Takes Almost 2 Months to Close
Image source: Getty Images.
While it doesn't influence our opinions of products, we may receive compensation from partners whose offers appear here. We're on your side, always. See our full
Don't Even Think About a Backdoor Roth IRA Contribution Until You've Done This
As we approach the end of what's been nothing short of an interesting year, many high-earning individuals and couples are now taking the time to reevaluate their retirement strategies. Given the
The Best 3D Printing Stocks of 2020: Are Any Buys for 2021?
As 2020 nears an end, we're going to look at the best-performing 3D printing stocks of the year, as of Dec. 24. Overall, this space outperformed the broader market. Moreover, the two biggest winners
These 3 Dividend ETFs Are a Retiree's Best Friend
Exchange-traded funds (ETFs) are great tools for retirees to gain diversified access to equities that fulfill investment goals, including income generation, stability, and growth. With thousands of
3 Energy Stocks to Buy in 2021
The turbulent ride of 2020 is finally coming to a close. Whether you had a market-beating investment year, did OK, or had a year you'd rather forget, now is the time to look ahead toward 2021.
The
Here's Why Tech Companies Are Fleeing Silicon Valley
In recent weeks, we've learned that tech heavyweights including Oracle (NYSE: ORCL) and Hewlett Packard Enterprise (NYSE: HPE) have decided to move their headquarters away from Silicon Valley. This
3 Year-End Retirement Moves to Make
For better or worse, 2020 is almost behind us. And while that's a good thing from a mental-health perspective (let's face it... we all want to be done with this year), it also means the clock is
3 Top Tech Stocks to Buy Before 2020 Is Over
The tech sector was the single biggest driver in the stock market's 2020 gains. Part of the remarkable performance stemmed from businesses and consumers rushing to digital channels amid
3 Things to Watch in Defense in 2021
The defense sector fell out of favor in 2020 as investors worried about long-term growth trends and focused their dollars instead on high-flying tech names.
Election years often weigh on defense, as
Could AstraZeneca's COVID Vaccine Still Succeed?
Two COVID-19 vaccines are already being given to Americans. But what about AstraZeneca (NASDAQ: AZN), which announced interim efficacy results from a late-stage clinical study of its coronavirus
The Most Important Number Virgin Galactic Investors Need to Know
All of a sudden, Wall Street loves space investing -- as evidenced by the "second annual space summit" that Morgan Stanley just held up in NYC earlier this month. Because of the coronavirus, MS held
Is Novavax Stock a Buy?
If you purchased just $10,000 in shares of vaccine drugmaker Novavax (NASDAQ: NVAX) at the beginning of the year, your investment would be worth a stunning $304,000 in less than 12 months. That kind
Got 10 Minutes? Here's How 3 Stock Investors Suggest Getting Started in 2021
It may be our imagination, but everyone seems happy that 2020 is finally coming to a close. Investors were challenged not only by the coronavirus pandemic, but also by the extreme volatility of the
Vaccination Expert: What Investors Should Watch In 2021
Even though the Moderna (NASDAQ: MRNA) and Pfizer (NYSE: PFE)-BioNTech (NASDAQ: BNTX) vaccines have been authorized for emergency use by the U.S. Food & Drug Administration, we still have plenty of
Looking for Top International Stocks? You Might Not Have to Look Very Far
There's no denying it: A lot of the world's best investing opportunities will happen outside of the United States over the coming years and decades. For this reason, investors should look for
This Top-Performing Stock Is No Longer in Robinhood's Top 100
This has been one of the wildest years on record for the stock market. Investors experienced about a decade's worth of volatility between late February and late August, with the benchmark S&P 500
You Can't Even Begin to Plan for Retirement Without This Number
One of the hardest truths of retirement planning is that you're never going to get it right. Just like today's retirees never could've foreseen the pandemic and recession we're currently living
Ask A Vaccine Specialist: What Does The Future of the mRNA Platform Hold?
Recently authorized coronavirus vaccines from Moderna (NASDAQ: MRNA) and the Pfizer (NYSE: PFE)-BioNTech (NASDAQ: BNTX) team are the first messenger RNA (mRNA) vaccines ever to be commercialized
3 Stocks I'm Never Selling
There are lots of stocks in my portfolio, and while some may be shorter-term holdings, others have been in it for many years and are likely to remain in it a decade or two from now. What are the
3 Top Investing Trends for the Next Decade
Investing success is underpinned by owning great businesses that can grow their earnings and deliver steady returns to investors for many years. And the companies that have the best prospects are
Is Teladoc Health in Trouble if Amazon Jumps Into Telehealth?
Could Amazon (NASDAQ: AMZN) be about to throw its hat into the ring in the telehealth market? Recent reports indicate that it could be likely. The e-commerce giant launched telehealth services for
Pfizer's Pipeline Candidate That Could Be a Bigger Winner Than Its COVID Vaccine
Here's a prediction for 2021 that doesn't require any fortune-telling skills at all: Pfizer's (NYSE: PFE) COVID-19 vaccine will soon become a megablockbuster. The big drugmaker's U.S. and European


